Frontiers in Psychiatry
May 23, 2022
Raquel Bennett, Christian Yavorsky, Gary Bravo
12 citations
Bipolar disorder (type 1) is a serious and chronic psychiatric illness that can be difficult to treat. Many bipolar patients have refractory depressive episodes. Racemic ketamine, a glutamate modulator with prominent dissociate and psychedelic properties, has been demonstrated to have rapid acting antidepressant and anti-obsessional effects which may be useful for treating the symptoms of...
Journal of Humanistic Psychology
April 1, 2004
Huston Smith, Charles S. Grob, Robert L. Jesse et al.
29 citations
Four decades ago, Huston Smith published one of the mostinfluential articles ever written on psychedelics, titled “Do Drugs HaveReligious Import?” As part of “The Oral History of PsychedelicResearch Project,” he was interviewed and invited to revisit thistopic. The interview covers his personal experiences, as well as the influences of psychedelic experiences on religious traditions...
The Journal of Nervous and Mental Disease
June 1, 1992
Mitchell B. Liester, Charles S. Grob, Gary Bravo et al.
130 citations
3,4-Methylenedioxymethamphetamine (MDMA) has been at the center of a debate over its potential benefits as an adjunct to psychotherapy versus its capability for neurotoxic effects and is currently classified as a Schedule 1 drug by the Drug Enforcement Administration (DEA). However, as yet, there is very little methodological data on the subjective experience of the MDMA-induced state or its...
The Journal of Nervous and Mental Disease
June 1, 1992
Charles S. Grob, Gary Bravo, Roger Walsh et al.
21 citations
GROB, CHARLES S. M.D.; BRAVO, GARY L. M.D.; WALSH, ROGER N. M.D., Ph.D.; LIESTER, MITCHELL B. M.D. Author Information
Journal of Psychoactive Drugs
1989
Gary Bravo, Charles S. Grob
38 citations
This article reviews the role of psychedelic drugs as potential tools for psychiatric research and practice. The decline in the utilization of these substances is linked to social reactions, which led to psychedelics being scheduled as controlled substances and consequently unavailable for human research. Three different paradigms for the use of psychedelics in psychiatry are reviewed: the...